M&A Deal Summary

Axonics Acquires Contura

On February 25, 2021, Axonics acquired medical products company Contura for 200M USD

Acquisition Highlights
  • This is Axonics’ 1st transaction in the Medical Products sector.
  • This is Axonics’ largest (disclosed) transaction.
  • This is Axonics’ 1st transaction in the United Kingdom.

M&A Deal Summary
Date 2021-02-25
Target Contura
Sector Medical Products
Buyer(s) Axonics
Deal Type Add-on Acquisition
Deal Value 200M USD

Target

Contura

London, United Kingdom
Contura Ltd. specializes in the distribution and sale of healthcare products, both pharmaceuticals, and medical devices, focused primarily on women’s health. Its lead products are Bulkamid, Aquamid, Regurin XL, and Cystistat. It also has a number of ongoing development programs focused upon additional uses of its proprietary hydrogel technology, such as Arthrosamid for the treatment of osteoarthritis in the knee. Contura is based in London, United Kingdom.

Search 202,196 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Axonics

Irvine, California, United States
Category Company
Founded 2012
Sector Medical Products
Revenue 274M USD (2022)
DESCRIPTION

Axonics is focused on the development and commercialization of differentiated devices to treat urinary and bowel dysfunction. The Axonics product portfolio includes the Axonics R20TM and the Axonics F15TM Systems used to deliver sacral neuromodulation (SNM) therapy. SNM therapy is a minimally invasive procedure used in the treatment of OAB and fecal incontinence. It works by delivering mild electrical pulses to the sacral nerve to restore communication between the brain and the bladder. Axonics was founded in 2013 and is headquartered in Irvine, California.

DEAL STATS #
Overall 1 of 2
Sector (Medical Products) 1 of 2
Type (Add-on Acquisition) 1 of 1
Country (United Kingdom) 1 of 1
Year (2021) 1 of 1
Size (of disclosed) 1 of 1
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2023-04-24 Radian

United States

Radian is a provider of medical products. Radian is based in United States.

Buy -
Mergr

Product

Company

Legal